Abstract:Lining Huang, 1 Zhaoxiang Wang, 1 Ying Pan, 1 Kaixin Zhou, 2 Shao Zhong 1 1 Gusu School, Nanjing Medical University, the First People's Hospital of Kunshan, Kunshan, 215300, People's Republic of China; 2 Guangzhou Laboratory, Guangzhou, 510005, People's Republic of China Correspondence: Shao Zhong, Department of Endocrinology, Gusu School, Nanjing Medical University, the First People's Hospital of Kunshan, Kunshan, 215300, People's Republic of China, Tel +86 13328056828, Email Objective: Type 2 diabetes mellitus (T2DM) is a metabolic disease characterized by insulin resistance and progressively impaired insulin secretion resulting in dynamic fluctuations in glucose levels.High blood urea nitrogen (BUN) levels have been linked to decreased insulin sensitivity, suppressed insulin synthesis and increased risk of incident diabetes mellitus in humans as well as insulin use in patients with T2DM.This study characterize the association between BUN levels and short-term and long-term glycemic variability(GV) in the elderly patients with T2DM who were hospitalized. Methods: A total of 927 elderly patients with T2DM were included in the study. The short-term GV was quantified using parameters such as standard deviation (SD), coefficient of variation (CV), time in range (TIR), and mean amplitude of glycemic excursions (MAGE), based on multi-point fingertip blood glucose monitoring. The long-term GV was quantified using parameters such as SD, CV, variation independent of the mean (VIM), and average successive variability (ARV), based on fasting blood glucose(FPG). The relationship between BUN levels and short-term and long-term GV in elderly T2DM who were hospitalized was explored using methods such as Spearman correlation coefficient, linear regression analysis, logistic regression analysis, and interaction tests. Results: In elderly patients with T2DM were hospitalized, there is a significant correlation between BUN levels and both short-term and long-term GV. BUN is negatively correlated with the GV parameter TIR (r=− 0.12, P =0.000), and positively correlated with SD (r=0.12, P =0.000), CV (r=0.07, P =0.026), MAGE (r=0.11, P =0.001), FPG-SD (r=0.08, P =0.013), and FPG-CV (r=0.08, P =0.014).Furthermore, the association remains consistent across different age, gender, BMI, and haemoglobin A1c (HbA1c) subgroups ( P interaction > 0.05). Conclusion: In elderly patients with T2DM were hospitalized, BUN levels were positively associated with GV.Therefore, monitoring BUN levels were beneficial in assessing the degree of GV. Keywords: diabetes mellitus, glycemic variability, vascular lesions of diabetes mellitus, glycemic variability parameters Glycemic variability (GV), also known as blood glucose fluctuations, refer to the dynamic changes in blood glucose levels between high and low values. It encompasses two main categories: long-term GV, which refers to the variations in blood glucose levels over a period of weeks to months, or even years, during long-term follow-up, including the fluctuations in haemoglobin A1c (HbA1c), fasting plasma glucose(FPG), or postprandial blood glucose; 1 and short-term GV, which represents the variations in blood glucose levels within a day or between different times of the day. Clinical physicians often use GV parameters such as standard deviation (SD), coefficient of variation (CV), time in range (TIR), mean amplitude of glycemic excursions (MAGE), variation independent of the mean (VIM), and average successive variability (ARV) to quantify short-term and long-term GV. Among these, SD, CV, TIR, and MAGE are generally used to quantify short-term GV, while FPG standard deviation (FPG-SD), FPG coefficient variation (FPG-CV), FPG variation independent of the mean (FPG-VIM) and FPG average successive variability (FPG-ARV) are primarily used to quantify long-term GV. Variations in blood glucose levels may increase risk of incident diabetes-related consequences such as kidney disease, retinopathy, heart and neurological complications. The activation of platelets, oxidative stress pathways, endothelial cell dysfunction, and chronic inflammation are thought to be the root causes of these problems. 2–4 The development and occurrence of microalbuminuria, diabetic nephropathy(DN), 5 diabetic retinopathy(DR), and cardiovascular autonomic neuropathy(CAN) can all be slowed down by maintaining TIR. 6 Furthermore, TIR is significantly negatively correlated with cardiovascular disease and increased risk of all-cause mortality. 7 Long-term GV parameters such as FPG-SD, FPG-CV, HbA1c-SD, and HbA1c-CV at a follow-up of 24 months are risk predictors -Abstract Truncated-

Correlation Between Blood Urea Nitrogen and Short- and Long-Term Glycemic Variability in Elderly Patients with Type 2 Diabetes Mellitus Who Were hospitalized:A Retrospective Study

Association of Visit-to-Visit Variability of Blood Pressure with Cardiovascular Disease among Type 2 Diabetes Mellitus Patients: A Cohort Study

Prognostic Value of Visit-to-visit Systolic Blood Pressure Variability Related to Diabetic Kidney Disease among Patients with Type 2 Diabetes.

Association of Various Glycemic Variability Indices and Vascular Outcomes in Type-2 Diabetes Patients

Excessive visit-to-visit glycemic variability independently deteriorates the progression of endothelial and renal dysfunction in patients with type 2 diabetes mellitus

Clinical implications and pharmacological considerations of glycemic variability in patients with type 2 diabetes mellitus

Long-term Visit-to-Visit Variability in Hemoglobin A1c and Kidney-Related Outcomes in Persons With Diabetes

Higher long-term visit-to-visit glycemic variability predicts new-onset atrial fibrillation in patients with diabetes mellitus

Low Blood Glucose Index Associated with Cardiovascular Events in Diabetic Hemodialysis Patients.

Relationship of Glucose Variability With Glycated Hemoglobin and Daily Mean Glucose: A Post Hoc Analysis of Data From 5 Phase 3 Studies

Visit-to-Visit Variability of Glycated Albumin Was Associated with the Risk of Diabetic Retinopathy in Patients with Type 2 Diabetes

Relationship between 24-h venous blood glucose variation and mortality among patients with acute respiratory failure

91-OR: Visit-to-Visit Variability of Glycated Albumin Was Associated with the Risk of Diabetic Retinopathy in Patients with Type 2 Diabetes

To What Extent Is HbA1c Associated with Glycemic Variability in Patients with Type 1 Diabetes? A Retrospective, Noninterventional Study

Association of long-term visit-to-visit glycemic variability with risk of adverse clinical outcomes in diabetic patients with heart failure with preserved ejection fraction

Association of HbA1c Variability with Vibrating Perception Threshold in Middle-Aged and Elderly Patients with Type 2 Diabetes Mellitus: A Retrospective Cohort Study

Association of HbA1c with All-cause Mortality Across Varying Degrees of Glycemic Variability in Type 2 Diabetes

Impact of short-term glycemic variability on risk of all-cause mortality in type 2 diabetes patients with well-controlled glucose profile by continuous glucose monitoring: A prospective cohort study

[Relationship Between Blood Glucose Variability and Microalbuminuria in Type 2 Diabetic Patients with Well-Controlled Glycosylated Hemoglobin].

Variability in Glycated Hemoglobin and Risk of Poor Outcomes Among People With Type 2 Diabetes in a Large Primary Care Cohort Study

Visit‐to‐visit HbA1c variability and risk of potentially avoidable hospitalisations in adults with type 2 diabetes receiving outpatient care at a tertiary hospital